...
首页> 外文期刊>Frontiers in Oncology >Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife
【24h】

Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife

机译:计划针对多发脑转移的放射外科手术的质量和治疗效率:非共面RapidArc与Gamma刀

获取原文
           

摘要

Objectives This study compares the dosimetry and efficiency of two modern radiosurgery [stereotactic radiosurgery (SRS)] modalities for multiple brain metastases [Gamma Knife (GK) and LINAC-based RapidArc/volumetric modulated arc therapy], with a special focus on the comparison of low-dose spread. Methods Six patients with three or four small brain metastases were used in this study. The size of targets varied from 0.1 to 10.5?cc. SRS doses were prescribed according to the size of lesions. SRS plans were made using both Gamma Knife~(?)Perfexion and a single-isocenter, multiple non-coplanar RapidArc~(?). Dosimetric parameters analyzed included RTOG conformity index (CI), gradient index (GI), 12?Gy isodose volume ( V _(12Gy)) for each target, and the dose “spread” (Dspread) for each plan. Dspread reflects SRS plan’s capability of confining radiation to within the local vicinity of the lesion and to not spread out to the surrounding normal brain tissues. Each plan has a dose (Dspread), such that once dose decreases below Dspread (on total tissue dose–volume histogram), isodose volume starts increasing dramatically. Dspread is defined as that dose when volume increase first exceeds 20?cc/0.1?Gy dose decrease. Results RapidArc SRS has smaller CI (1.19?±?0.14 vs. 1.50?±?0.16, p ?
机译:目的本研究比较了两种现代放射外科[立体定向放射外科(SRS)]模式用于多发性脑转移[伽玛刀(GK)和基于LINAC的RapidArc /体积调制弧光治疗]的剂量学和效率,特别着重于低剂量传播。方法本研究采用6例具有3或4个小脑转移的患者。目标的大小从0.1到10.5?cc不等。根据病变的大小开出SRS剂量。 SRS计划是使用Gamma Knife〜(?)Perfexion和单等中心,多个非共面的RapidArc〜(?)制定的。所分析的剂量参数包括RTOG合格指数(CI),梯度指数(GI),每个目标的12?Gy等剂量体积(V _(12Gy)),以及每个计划的“扩散”剂量(Dspread)。 Dspread反映了SRS计划将辐射限制在病变局部附近并且不扩散到周围正常脑组织的能力。每个计划都有一个剂量(Dspread),因此一旦剂量降低到Dspread以下(在总组织剂量-体积直方图上),则等剂量体积开始急剧增加。 Dspread定义为体积增加首次超过20?cc / 0.1?Gy剂量减少时的剂量。结果RapidArc SRS的CI较小(1.19±0.14 vs.1.50±0.16,p <0.001)和较大的GI(4.77±1.49 vs.3.65±0.98,p <0.01)。 V _(12Gy)结果是可比较的(2.73±±1.38 vs. 3.06±±2.20μcc,p≥0.58)。 V6,V4.5和V3的中等至较低剂量分布也相当。 GK计划实现了更好的极低剂量分布(≤3?Gy),并且Dspread值也略小,分别为1.9和2.5?Gy。 GK的总治疗时间估计为60至100分钟。与RapidArc处理技术相比,GK处理的时间长3至5倍。结论在多点测量中,比较了GK SRS和RapidArc SRS的反映处方剂量共形(CI),剂量下降(GI),放射坏死指示剂(V _(12Gy))和剂量分布(Dspread)的剂量参数。 RapidArc计划的CI较小,但GI较大。 V _(12Gy)是可比的。 GK似乎可以更好地减少极低剂量的扩散(<3?Gy)。与GK SRS相比,RapidArc SRS的治疗时间大大减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号